Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

Overcoming Ovarian Cancer's Resistance to Immunotherapy

Different forms of cancer cells and tumors have their own tricks for avoiding detection by the body's immune system altogether or otherwise sabotaging any attempts to muster an immune response. In the case of the most common and difficult-to-treat form of ovarian cancer, this ability to suppress the immune system also makes the cancer resistant to treatments known as immunotherapies that seek to supercharge immune cells. Scientists at Sanford Burnham Prebys and the University of California San Diego published findings February 25, 2026, in Cell Reports demonstrating a treatment approach in mice that allowed more tumor-fighting cells to approach tumors, shifted the behavior of other immune cells to work against tumors, and made immunotherapy more effective. The research team also uncovered what cellular changes prompted the immune system to better pierce the tumors' veil of immunosuppression.

March 5, 2026


March 5 2026

March 4 2026

March 3 2026

March 2 2026

March 1 2026

February 28 2026

February 27 2026

February 26 2026

February 25 2026

February 24 2026

February 23 2026

February 22 2026

February 21 2026

February 20 2026